Publication Library
A Practical Guide to the Clinical Implementation of Biomarkers for Subclinical Rejection Following Kidney Transplantation
Maarten Naesens MD PhD, John Friedewald MD, Valeria Mas MD PhD, Bruce Kaplan MD, Michael M. Abecassis MD MBA
Application of TruGraf v1: A Novel Molecular Biomarker for Managing Kidney Transplant Recipients With Stable Renal Function
Transplantation Proceedings Volume 51, Issue 3, April 2019, Pages 722-728
C.L. Marsh, S.M. Kurian, J.C. Rice, T.C. Whisenant, J. David, S. Rose, C. Schieve, D. Lee, J. Case, B. Barrick, V.R. Peddi, R.B. Mannon, R. Knight, D. Maluf, D. Mandelbrot, A. Patel, J.J. Friedewald, M.M. Abecassis, and M.R. First,
Investigator Assessment of the Utility of the TruGraf Molecular Diagnostic Test in Clinical Practice
Transplant Proc. 2019 Apr;51(3):729-733. doi: 10.1016/j.transproceed.2018.10.024
First MR, Peddi VR, Mannon R, Knight R, Marsh CL, Kurian SM, Rice JC, Maluf D, Mandelbrot D, Patel A, David J, Schieve C, Lee D, Lewis P, Friedewald JJ, Abecassis MM, Rose S
Development and Clinical validity of a novel blood-based molecular biomarker for sub-clinical acute rejection following kidney transplant
American Journal of Transplantation First published: 09 July 2018 https://doi.org/10.1111/ajt.15011
John J. Friedewald1, Sunil M. Kurian, Raymond L. Heilman, Thomas C. Whisenant, EmilioD. Poggio, Christopher Marsh, Prabhakar Baliga MD, Jonah Odim, Merideth M. Brown, David N. Ikle, Brian D. Armstrong, jane I. charette, Susan S. Brietigam, Nedjema Sustento-Reodica, Lihui Zhao, Manoj Kandpal, Daniel R. Salomon†, and Michael M. Abecassis*(ORCID 0000-0001-9333-463X), for the Clinical Trials in Organ Transplantation08 (CTOT-08)
Value of the TruGraf Blood Test as a Biomarker for Monitoring Renal Transplant Recipients
Insights in Biomedicine ISSN 2572-5610, April – 2018, vol.3 No.2:8
First MR, Rose S, Schieve C, Lee D, Lewis P, Pierry D, David J, McNulty M, Clark D, Weiss G, Kurian S, Whisenant T, Friedewald JJ and Abecassis MM
Clinical Utility of Peripheral Blood Gene Expression Profiling in Kidney Transplant Recipients to Assess the Need for Surveillance Biopsies in Subjects with Stable Renal Function
Journal of Transplant Technology & Research, November 2017, 7:3
Martin Roy First, Thomas Whisenant, John J Friedewald, Stan Rose, Darren, Lee, Sunil Kurian, Dierdra Pierry, Peter Lewis, Terri Gelbart, Michael M Abecassis
An Economic Analysis of the Cost Effectiveness of Blood Gene Expression Profiling in Kidney Transplant Recipients
Journal of Health & Medical Economics, July – 2017, ISSN 2471-9927 vol.3, 1:3
Roy First M, Darren Lee, Peter Lewis and Stan Rose
Analytical and Clinical Validation of a Molecular Diagnostic Signature in Kidney Transplant Recipients
Journal of Transplantation Technologies & Research, September – 2017, 7:3
Martin Roy First, Deirdre Pierry, Michael McNulty, Sunil M Kurian, Stan Rose, Thomas Whisenant, Terri Gelbart, April Venzon, Nadia Bayat, Peter Lewis, John J Friedewald, Michael M Abecassis and Darren Lee
Biomarker Guidelines for High-Dimensional Genomic Studies in Transplantation: Adding Method to the Madness
Transplantation March 2017 Volume 101 Number 3
Sunil M. Kurian, PhD, Thomas Whisenant, PhD, Valeria Mas, PhD, Raymond Heilman, MD, Michael Abecassis, MD, Daniel R. Salomon, MD, Adyr Moss, MD, and Bruce Kaplan, MD
Orthogonal Comparison of Molecular Signatures of Kidney Transplants With Subclinical and Clinical Acute Rejection: Equivalent Performance Is Agnostic to Both Technology and Platform
American Journal of Transplantation Jan. 2017; 17: 2103 – 2116
S. M. Kurian, E. Velazquez, R. Thompson, T. Whisenant, S. Rose, N. Riley, F. Harrison, T. Gelbart, and J. J. Friedewald, J. Charette, S. Brietigam, J. Peysakhovich, M. R. First, M. M. Abecassis and D. R. Salomon